R. Andrew Eckert serves as a director of BD (Becton, Dickinson and Company), a global medical technology company headquartered in Franklin Lakes, New Jersey. Eckert has been a member of the board since 2016.
Mr. Eckert serves as a Senior Advisor to Permira, a global private equity firm, since 2023. Since July 2025, he has served as Board Chairman of Lytx, Inc., a technology company that designs, manufactures and sells video telematics products, after joining the Board of Directors in December 2024 and serving as Interim CEO from December 2024 to June 2025. From August 2020 to August 2021, Mr. Eckert served as CEO of Zelis Inc., a provider of healthcare cost management and payments solutions. From 2017 until the sale of the company in October 2019, he served as president and CEO of Acelity L.P. Inc., a global wound care company. From 2015 until the sale of the company in 2016, Eckert served as CEO of Valence Health, Inc., a healthcare information technology and services company. Eckert also serves as Board Chairman of the board of directors of Maravai LifeSciences.
Eckert is a leader in the growing field of healthcare information technology, with extensive experience as an executive officer of several healthcare companies. He also brings to the Board a deep knowledge of operations, strategic planning, product development and marketing and has valuable corporate governance insight gained from having served as chief executive officer of publicly-held companies and board member of public companies.